Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 7 (304), 304ps18

Hurdles in Therapy With Regulatory T Cells

Affiliations
Review

Hurdles in Therapy With Regulatory T Cells

Piotr Trzonkowski et al. Sci Transl Med.

Abstract

Improper activation of the immune system contributes to a variety of clinical conditions, including autoimmune and allergic diseases as well as solid organ and bone marrow transplantation. One approach to counteract this activation is through adoptive therapy with regulatory T cells (Tregs). Efforts to manufacture these cells have led to good maunfacturing practice-compliant protocols, and Treg products are entering early clinical trials. Here, we report the stance of the European Union Cooperation in Science and Technology Action BM1305, "Action to Focus and Accelerate Cell-based Tolerance-inducing Therapies-A FACTT," which identifies hurdles hindering Treg clinical applications in Europe and provides possible solutions.

Similar articles

See all similar articles

Cited by 60 PubMed Central articles

See all "Cited by" articles

Publication types

LinkOut - more resources

Feedback